Health ❯ Obesity ❯ Treatment

Medications

Semaglutide GLP-1 GLP-1 Drugs GLP-1 Therapies GLP-1 Agonists GLP-1 Receptor Agonists Oral Semaglutide Tirzepatide Weight Loss Jabs GLP-1 Medications GLP-1 Therapy Poviztra Weight-loss Pills Liraglutide Weight-loss drugs Long-term Effects Wegovy Liraglutida GLP-1 Analogues Nutritional Deficiencies GLP-1 Treatments Risks of Counterfeits Lifestyle Changes Guidelines Weight Loss Drugs Injectable Drugs GLP1 Receptor Agonists Obesity Medications

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Early phase 2 results show the drug kept about half of lost lean mass without reducing overall weight loss; larger and longer trials are needed before it could be used in patients.

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide